Trial
NCT02353572
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Plasma Cell Myeloma
Intervention
Melphalan
Why stopped
Principle investigator left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-09